bibliographicCitation |
He Z, Mo J, Jiang W, Zhu J, Yang S, Gao S, Lam K, Li Y, Qiu K, Huang M, Wu J. Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database. Int J Gynecol Cancer. 2023 Aug 07;33(8):1237–46. doi: 10.1136/ijgc-2022-004042. PMID: 37164363. |